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Sarlo E.G., Medici S.K., Porrini M.P., Garrido M., Floris I., Euguaras M.J. – Comparison between different fumagillin
dosages in the apiary control of Nosemosis type C.
Fumagillin (dicyclohexylammonium) is an antibiotic with well-known microsporicidal activity widely used to
control Nosema disease caused by Nosema apis in honeybees. Its use is permitted by law in Argentine and USA, but
not in the EU countries, apart from specific cases under veterinary authorization. So far, the optimal dosage of this
active ingredient in controlling Nosema ceranae has not been determined. The aim of the present work was to assess
the efficiency of different fumagillin dosages on Apis mellifera colonies affected by different N. ceranae intensity. For
this purpose, during April and May of 2007, in an apiary located near the Mar del Plata city (Buenos Aires Province,
Argentine), forty eight A. mellifera colonies reared in Langhstroth hives, each containing 8 to 10 adult bee combs,
were used in order to evaluate the effectiveness of different doses of fumagillin. The colonies were divided into those
with mild or semi-severe disease intensity, based on the number of Nosema spores estimated in a sample of 60 return-
ing bees (arb, spores abundance in returning bee). Then the colonies were randomly distributed forming 6 experi-
mental groups (3 with mild intensity: one untreated left as control and the other two treated with 102 mg of fumag-
illin in two and three doses, respectively; 3 with semi-severe intensity: treated with 102 mg of fumagillin in two and
three doses, and with 120 mg of fumagillin in four doses, respectively). Each dose was administered at intervals of 7
days. Before and during each administration, for a period of 35 days, the number of frames covered with adult bees
was recorded in each hive and a sample of 100 workers per colony was collected from the hive entrance in order to
determine the abundance (arb) and prevalence (prb) of spores. This alternative parameter (prb) was calculated by
examining a sub-sample of 10 bees, crushing the propodeum of the bees in 0.5 ml distilled water, taking a drop of
suspension and observing 20 fields under a optic microscope (450x) for spore absence (0) or presence (1); then the
estimation of spores prevalence (prb) was recorded as percentage of spore presence in the 20 observed fields, and
the average of two estimates were used. Moreover, spores from 5 randomly selected colonies were molecularly char-
acterized to confirm the Nosema species. The sequencing results showed a 98% of homology with N. ceranae. The
results obtained allow to establish that the efficiency of fumagillin in controlling Nosemosis type C caused by N. cer-
anae is affected by the intensity of the disease rather than from dosage or way of application. The best result was
obtained when colonies were affected by a mild intensity and the drug was administered in two weekly doses of 51
mg per hive.
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INTRODUCTION
Nosema ceranae (Microsporida, Nosematidae) is a
microbial intracellular parasite of adult honeybees with
worldwide distribution (KLEE et al 2007) known to infect
the Asian honey bee, Apis cerana, and the European
honey bee, Apis mellifera. It is responsible for the disease
named Nosemosis type C (COLOSS Workshop, 2009)
and for considerable economic losses among beekeepers
(FRIES, 2010). Affected hives show low production and
high bee mortality, and need to be treated with
antibiotics for the control of this disease (FAUCON, 2002;
HIGES et al., 2006a).
While in the EU countries fumagillin (dicyclohexy -
lammonium) is generally not allowed (apart from specific
cases under veterinary authorization), in the USA and
Argentine it is regularly registered for use in beekeeping
and represents a well-known and widely used antibiotic
for the control of the honeybee Nosemosis (KATZNELSON
and JAMIESON, 1952; GOCHNAUER and FURGALA, 1969;
HARTWIG and PRZELECKA, 1971; WEBSTER, 1994; SARLO
et al. 2002; SARLO et al. 2006). However, the efficiency of
this active ingredient in the control of Nosemosis type C
caused by Nosema ceranae remains unclear, varying either
for pharmacological parameters and dosage or due to
intrinsic factors like haplotype (WILLIAMS et al., 2008) or
the intensity of the disease in the honeybee colonies.
HIGES et al. (2006b) reported a complete efficacy after
the administration of 120 mg, while WILLIAMS et al.
(2008) have established that higher doses (168 mg) gave
only a temporary effect. The importance of unwanted
side-effects that this antibiotic may exert on bees (LIU,
1990a, b; RADA et al. 1997) and humans (STANIMIROVIC et
al., 2006) by the possible honey contamination is
considered adverse (ASSIL and SPORNS, 1991, STE -
VANOVIC et al., 2000). However, it is essential a pro per
dosage optimization for this conventional antibiotic in
the hive treatments. 
The aim of the present work was to asses the efficiency
of Fumagillin dosage in relation to different Nosemosis
type C intensity in Apis mellifera colonies.
– Received 4 July  2011     Accepted 20 September 2011      Published 1 December 2011
MATERIAL AND METHODS
Experiments were conducted between April and May
2007, using 48 Langhstroth colonies of A. mellifera,
located near Mar del Plata city, in the Buenos Aires
Province, Argentine (37º 56’ 02,29’’ S; 57º 40’ 57,63’’ W).
Environmental conditions are specified in table 1. 
Forty eight colonies of A. mellifera in Langhstroth hives,
each with 8 to 10 combs of adult bees, were first evaluated
for the Nosemosis intensity. For this purpose, the mean
number of spores per bee in a sample of 60 returning bees
per hive was obtained using a haemocytometer
(CANTWELL, 1970) and according to FRIES (1988) in order
to obtain a 95 % of significance level. Because not all the
bees in the sample are necessarily infected, it is proposed
in this paper to consider the spore number obtained as the
“spores abundance in the returning bees” (arb). After
obtaining the arb values, the colonies were divided based
on their infection level: 24 in the mild level and 24 in the
semi-severe level according to JACOX scale (1980). Then
the colonies were randomly distributed into six
experimental groups (N=8), three of which with mild
intensity (N=24) and the other with semi-severe intensity
(N=24) ( 2). 
The administration of fumagillin at various doses (2, 3 or
4), concentrations (0, 30, 34, 51 mg/dose per treatment)
and total amounts (0, 102 or 120 mg/hive) was performed
at 7-day intervals, supplied in 500 ml sugar syrup (66%
w/v) according to GOCHNAUER and FURGALA (1969). The
solution was given with an inner feeder at 16:00 (GTM).
Total solution removal was complete after 24 hours. The
treatment for each group is shown on Table 2.
During the trial (35 days), once a week, the number of
frames covered by bees per each colony were recorded
between 09:00 and 11:00 (GTM) and a sample of 100
returning bees was collected from each hive between 13:00
and 14:00 (GTM). The bee samples were conserved using
a 4% formaldehyde solution until examination of bees to
determine the abundance of spores (arb, N 60) and the
prevalence of spores (prb, N 10). This last additional
parameter was used as alternative evaluation of the
effectiveness of the treatment by examining a sub-sample
of 10 bees. The spore suspension for each bee was
obtained by adding 0.5 ml distilled water to crushed
abdomen collected after propodeum ablation. A drop of
the suspension was examined under optic microscope
(450X) for spores observation. Estimation of prevalence of
spores (prb) was recorded as percentage of spore presence
in 20 observed fields, and the average of two estimates
were used. 
After confirming the spores presence by microscopic
analysis, purification was conducted according to COLE
(1970) and molecularly characterized following the
MARTIN-HERNÁNDEZ et al. (2007) method. The PCR
fragments were purified and sequenced in the Pro-papa
Laboratory EEA, INTA, Balcarce, Argentine. Afterward,
they were sequenced and matched with respect to those
published in the GENBANK (NCBI).
Finally, the data were analysed by non parametric
Krustal Wallis and Mann Whitney test (XLSTAT® 2008).
RESULTS
After multiplex PCR, the fragments obtained from the
spore samples, exhibited only a band corresponding to
218 bp in agreement with MARTÍN-HERNÁNDEZ et al.
(2007). Sequencing results were entered in the
GENBANK BLASTn, which yielded 98% homology with
N. ceranae (accession N° FJ425736).
The fumagillin treated groups showed a significant
reduction in the arb of spores after 35 days of treatment
[Mann-Whitney, p-value (bilateral) < 0.0001, a = 0.05]
(fig. I). The effectiveness estimated by this indicator was
calculated as a percentage of decrease for each group.
This percentage was over 91% for every groups, while
the control group showed an increase of the arb spores,
with final values of 10.707.500 ± 2.188.331 SD spores per
bee (Table 3). More precisely, final arb values of groups
with mild degree (2a and 2b) resulted significantly lower
than semi-severe degree groups (3a and 3b) [Mann-
Whitney / p-value (unilateral) < 0.0001 a = 0.05). These
groups (3a and 3b] did not present significant differences
respect to Group 4 (dose of 120 mg) at the end of the
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Table 1 – Environmental conditions prevailing during the experiment. 
Month Max. Temp.* Min Temp. * Medium Temp.* Med Rel. Hum..* Rainfall*
(ºC) (ºC) (ºC) (%) (mm)
April 20.37 9.37 14.90 82.33 19.86
May 14.10 4.97 9.56 84.81 2.90
*Average monthly weather (Fuente EEA INTA Balcarce). The months correspond to autumn in the southern
hemisphere.
Table 2 – Treatment groups formed from mild degree colonies (1 - 2 x106 spores/ bee) and semi severe (10 - 15 x106 spores/ bee) accor-
ding to Jaycox scale.
Group Number Nosemosis intensity Number of mg of fumagillin / Total mg. of 
of colonies (abundance of spores/bee) doses per hive dose / hive fumagillin/ hive.
Control (1) 8 mild 4 0 0
2a 8 mild 2 51 102
2b 8 mild 3 34 102
3a 8 semi-severe 2 51 102
3b 8 semi-severe 3 34 102
4 8 semi-severe 4 30 120
treatment [Kruskal-Wallis p-value (bilateral) 0.510, a =
0.05]. 
The administration of 102 mg of Fumagillin in 2 or 3
doses did not present significant differences in final arb
values among the mild degree groups 2a and 2b [Mann-
Whitney p-value (bilateral) 0.294 a = 0.05] and between 3a
and 3b [Kruskal-Wallis p-value (bilateral) = 0.510;  a =
0.05].
The effectiveness of treatments, estimated as the
decrea se or increase percentage of prb values obtained on
days 0 and 35 are shown on table 4. Mild grade groups,
treated with 102 mg (2a and 2b) did not show significant
differences on final prb [Mann-Whitney p-value
(bilateral) 0.732 a = 0.05), but there was a significant
reduction comparing to initial prb [Mann-Whitney p-
value (unilateral) < 0.0001 a= 0.05]. Groups 3a and 3b
with semi-severe spore load, did not show significant
differences on initial [Mann-Whitney p-value (bilateral)
0.198 a = 0.05] or final prb values [Mann-Whitney p-
value (bilateral) 0.694 a = 0.05].
Table 5 shows the initial and final numbers of bee
frames. Treated groups with mild intensity of disease (2a
and 2b) did not suffer a reduction in their consistence,
while groups with semi-severe intensity suffer of a
sensible reduction in the adult bee consistence from day
21 onwards (fig. II).
DISCUSSION AND CONCLUSION
The reduction higher than 90% of N. ceranae spores
upon the totality of the colonies treated with fumagillin
appears to be significant regardless of dosage or the initial
abundance of spores. However, the fact that all the groups,
independently of the dosage and the initial parasitosis
degree, showed a certain spore load at the end of the
treatment (particularly the semi severe group), could
indicate that despite the drastic reduction of the parasite
development, the remaining spores will continue
multiplying over time. This situation could explain the
temporality of the treatment observed by WILLIAMS et al.
(2008) or the effectiveness loss of the fumagillin as
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Figure I – Mean abundance of spore per bee (arb) recorded weekly during a period
of 35 days. Y axis is represented in logarithmic scale. 
Table 3 – Mean abundance of speres (arb) and Fumagillin effectiveness of the groups obtained at 0 and 35 days
from the beginning of the treatment.
Group Initial mean abundance Final mean abundance Effectiveness 
(arb ±SD) (arb ±SD) (%) ± SD
Control (1) 1 976 625 ± 559 933 a 10 707 500 ± 2 188 331 a -
2a 1 768 750 ± 573 384 a 45 000 ± 18 028 b 97.46 ± 0.89
2b 1 432 500 ± 235 160 a 57 500 ± 25 355 b 95.96 ± 1,67
3a 12 938 000 ± 1 434 727 b 669 375 ± 409.394 c 94.93 ± 2.80
3b 11 336 875 ± 4 532 981 b 820 000 ± 424 845 c 91.74 ± 5.36
4 13 233 125 ± 2 079 411 b 428 750 ± 119 006 c 96.63 ± 1.33
Different letters (a, b, c) indicate significant differences.
proposed in other investigations (COLOSS Workshop,
2009). 
Anyway, based on our results, the experimental
administration of 102 mg antibiotic is the most efficient
amount of active ingredient in controlling this parasitosis
after 35 days from the beginning of the treatment. On the
other hand, if the administration of 102 mg on colonies
with mild degree of parasitosis does not eliminate totally
the parasite, causes reductions of spore load (arb) at levels
harmless to the colonies. This temporality is essential to
control the parasitosis in production apiaries, because if
the Autumnal treatment is applied on mild level colonies,
the lower spores load remaining probably will not generate
the necessary number of parasites to affect adversely the
colonies during Spring. Thus, spring treatments could be
avoided, as suggested by BOTÍAS et al. (2009) for a rational
use of this drug, allowing the natural colonies restoration
during summer as observed by PICKARD and EL-SHEMY
(1989) with N. apis.
The absence of differences in the abundance of spores
(arb) (Tab. 3) relative to the different ways of application
tested, could indicate the achievement of a higher efficiency
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Figure II – Mean number of bee frames per colony of each group recorded weekly
during a period of 35 days.
Table 5 – Mean values of number of bee frames per hive and related reduction percentage at the
beginning and at the end of the treatment. 
Group Initial number of bee Final number of  bee Decrease
frames (average) ±SD frames (average) ±SD (%)
Control (1) 9.63 ±0.74 a 9.13±0.64 a 5.2
2a 9.63±0.52 a 9.63±0.52 a 0
2b 9.75±0.46 a 9.75±0.46 a 0
3a 9.5±0.53 a 6.25±1.16 b 34.2
3b 9.38±0.74 a 6.75±1.39 b 28.0
4 9.5±0.76 a 6.63±1.06 b 30.2
Different letters(a, b, c) indicate significant differences.
Table 4 – Mean prevalence of spores (prb) and fumagillin effectiveness of the groups obtained at 0
and 35 days from the beginning of the treatment.
Group Initial prevalence Final prevalence Effectiveness 
(prb ± SD) (prb ± SD) (%) ± SD
Control (1) 41 ± 12 a 97 ± 5 a –
2a 40 ± 13 a 11 ± 2 b 67.41 ± 15.72
2b 34 ± 16 a 10 ± 5 b 59.54 ± 45.22
3a 72 ±18 b 81 ± 21 c -14.11 ± 20.47
3b 98 ±7 b 81 ± 12 c 17.33 ± 9.96
4 96 ± 9 b 88 ± 17 c 6.31 ± 23.87
Different letters (a, b, c) indicate significant differences. 
with two doses (51 mg fumagillin), regardless of the initial
spores load, but related only to colonies with mild level of
Nosemosis. Infact, if final prevalence of spores (prb) (Tabs
4 and 5) is considered as a parameter of evaluation, we can
conclude that administering that dosage on colonies with
semi-severe loads will not reduce the number of parasitized
individuals with the subsequent bee population loss.
Hence, the results of this investigation lead to conclude
that the maximum efficiency of fumagillin is obtained
treating the colony when parasitosis abundance does not
exceed the mild degree (asymptomatic) in two applications
of 51 mg. The Autumn treatment of colonies with semi
severe grade has determined a significant reduction in arb
values. However, it is necessary to consider the effect
caused by the mass mortality of highly parasitized adult
bees recorded 21 days after treatment (fig. I) as proved also
by the reduction of bee frames (fig. II). The high
prevalence of spores (prb) of those experimental groups
which had bee loss, indicates that under these conditions,
the information provided by this alternative estimator is
better than the one given by the arb for assessing the
parasitosis status. Infact, by this parameter we can show
that colonies with semi-severe degree of Nosemosis are still
exposed to serious risks beyond the apparent effect of the
treatment on the reduction of spore load recorded in the
bees, and the treatment is not able to prevent damages of
the parasitosis, even temporarily.
Finally, based on the above results, it could be
postulated that preventive evaluation of the parasitosis
degree on returning bees is a valid and necessary tool in
the pharmacological control of Nosemosis type C using
fumagillin. The control efficiency is more related to the
parasite load at the beginning of the treatment rather than
the active ingredient amount or the way of administration. 
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